Evidence map›Paper›PMID 31792217›Full record

ArticleNature communications2019

Declines in HIV incidence among men and women in a South African population-based cohort.

Alain Vandormael, Adam Akullian, Mark Siedner, Tulio de Oliveira, Till Bärnighausen, Frank Tanser

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 3 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 3 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Alain VandormaelAfrica Health Research Institute (AHRI), Private Bag X7, Durban, 4013, South Africa. vandormaela@ukzn.ac.za.ORCID http://orcid.org/0000-0002-5742-0511
Adam AkullianInstitute for Disease Modeling, Bellevue, Washington, 98005, USA.ORCID http://orcid.org/0000-0001-8247-2172
Mark SiednerAfrica Health Research Institute (AHRI), Private Bag X7, Durban, 4013, South Africa.
Tulio de OliveiraKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, UKZN, Durban, 4013, South Africa.
Till BärnighausenAfrica Health Research Institute (AHRI), Private Bag X7, Durban, 4013, South Africa.
Frank TanserAfrica Health Research Institute (AHRI), Private Bag X7, Durban, 4013, South Africa.
Heidelberg University · DEUniversity of Washington · USCentre for the AIDS Programme of Research in South Africa · ZAHarvard University · US

Funding

Causal Pathways to population health impact of HIV antiretroviral treatmentR01HD084233 · NICHD · UNIVERSITY OF KWAZULU-NATAL · PI BARNIGHAUSEN, TILL, TANSER, FRANK COURTENEY · 2015 to 2021
$2.3M
Can HIV Hot-Spots be eradicated? An intervention to decrease HIV transmission to young women in rural KwaZulu-Natal South AfricaR01AI124389 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI BARNIGHAUSEN, TILL, TANSER, FRANK COURTENEY · 2016 to 2020
$2.1M
NIAID NIH HHS R01 AI124389NICHD NIH HHS R01 HD084233
6 · The paper itself

Abstract

Over the past decade, there has been a massive scale-up of primary and secondary prevention services to reduce the population-wide incidence of HIV. However, the impact of these services on HIV incidence has not been demonstrated using a prospectively followed, population-based cohort from South Africa-the country with the world's highest rate of new infections. To quantify HIV incidence trends in a hyperendemic population, we tested a cohort of 22,239 uninfected participants over 92,877 person-years of observation. We report a 43% decline in the overall incidence rate between 2012 and 2017, from 4.0 to 2.3 seroconversion events per 100 person-years. Men experienced an earlier and larger incidence decline than women (59% vs. 37% reduction), which is consistent with male circumcision scale-up and higher levels of female antiretroviral therapy coverage. Additional efforts are needed to get more men onto consistent, suppressive treatment so that new HIV infections can be reduced among women.

Indexed as

AdolescentAdultAnti-HIV AgentsCircumcision, MaleCohort StudiesFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedSouth AfricaYoung AdultAnti-HIV Agents

Identifiers

PMID31792217
PMCPMC6889466
OpenAlexW2990321742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.